You are here

Article info

Article menu

Download PDFPDF

XML
Therapeutics/Prevention
Randomised controlled trial
Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy

Authors

  1. Correspondence to : Dr Jenny Hill, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L37 3QA, UK; jenny.hill{at}lstmed.ac.uk
View Full Text

Citation

Hill J, Kuile FOT
Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy
BMJ Evidence-Based Medicine 2016;21:146-147.

Publication history

  • First published May 20, 2016.
Online issue publication 
June 07, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/